Navigation Links
Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
Date:6/24/2008

Presentations at Cardiostim World Congress Focus Attention on a New

Ablation Technology

CARLSBAD, Calif., June 24 /PRNewswire/ -- Ablation Frontiers, Inc. today announced that two studies reporting positive findings about its novel atrial fibrillation catheter ablation system were presented at this year's Cardiostim World Congress, a premier meeting for physicians that treat cardiac rhythm disorders.

Dr. Stefan Weber of the University Clinic at Regensburg, Germany, presented results of a study of 12 patients with paroxysmal atrial fibrillation (PAF). Using the company's PVAC(TM) (Pulmonary Vein Ablation Catheter) and GENius(TM) RF generator, Dr. Weber reported success in isolating 98 percent of pulmonary veins with a remarkably short average ablation time of 84 +/- 9 minutes. The total time of radiofrequency (RF) energy needed to successfully isolate the pulmonary veins was 22.4 +/- 2.9 minutes.

"We found that mapping and ablation of the pulmonary veins using a single catheter, without 3D navigation or robotic steering, could be performed safely and effectively with short procedure times," stated Dr. Weber. "Thus, this system may be of high interest for all centers who would like to increase throughput for AF ablation."

The second study, led by Dr. Christoph Scharf and presented by Dr. Lam Dang of Klinik Im Park Hospital in Zurich, Switzerland, utilized the same novel catheter ablation technology in a total of 45 patients with long standing persistent AF. This study utilized two additional catheters from Ablation Frontiers, MASC(TM) (Multi-Array Septal Catheter) and MAAC(TM) (Multi-Array Ablation Catheter) designed to find and ablate specific ablation targets called CFAEs (Complex Fractionated Atrial Electrograms). Six month follow up data was presented for 37 patients, with 78 percent free of AF after an average procedure time of 162 +/- 36 minutes. Dr Scharf noted the particularly low re-do procedure
'/>"/>

SOURCE Ablation Frontiers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
2. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
3. Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
4. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
5. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies
8. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
9. Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
10. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
11. Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)...  Three-month paliperidone palmitate, an investigational atypical antipsychotic, ... in patients with schizophrenia, according to a new ... the Journal of the American Medical ... of the study served as the basis for ... three-month paliperidone palmitate injection to treat schizophrenia in ...
(Date:3/27/2015)... , March 27, 2015 Across the global ... meeting challenges in clinical development, market education, and regulatory ... the Medical Affairs function is expected to increase in ... According to research by benchmarking firm, ... a group dedicated to Medical Affairs. Among companies in ...
(Date:3/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced the issuance of an aggregate of 30,000 ... and an aggregate of 120,500 stock options to employees ... vest over three years and will be exercisable for ... of $1.40 per stock option. About Covalon ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Covalon Announces Issuance of Stock Options 2
... Aug. 8, 2011 Systech International®, the recognized global ... leading systems engineering, automation, and manufacturing optimization services company, ... for the pharmaceutical market in Puerto Rico.  VCG now ... Systech and their extensive customer-base in region. ...
... 2011 - Pharmasset, Inc. (Nasdaq: VRUS ) announces ... to be held August 10 to 11, 2011 at the ... Executive Officer, will provide an overview of the company at ... 9:30 AM (ET). To access a simultaneous webcast ...
Cached Medicine Technology:Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3Pharmasset to Present at Canaccord Genuity Growth Conference 2Pharmasset to Present at Canaccord Genuity Growth Conference 3
(Date:3/29/2015)... (PRWEB) March 30, 2015 Over 50 ... symptoms tied to undiagnosed autoimmune, thyroid, or hormone disorders. ... disorders, has personally treated hundreds of patients dealing with ... unaware of the treatment options for their ailments. Her ... solutions to women living with fatigue, brain fog, and ...
(Date:3/29/2015)... 29, 2015 Women’s Excellence , ... Secondary to their location in Birmingham, they now ... They continue to be affiliated with Crittenton, St. ... Menopause is a normal condition that all women experience ... of the changes a woman goes through either just ...
(Date:3/29/2015)... Nashville, TN (PRWEB) March 29, 2015 ... insurance that agencies promote nationally on the web can ... of permanent life insurance quotes can now be explored ... http://quotespros.com/life-insurance.html . , Learning the differences between what ... offers can be a challenge for some men and ...
(Date:3/29/2015)... March 29, 2015 The culmination of one ... coming when the Final Four invades Lucas Oil ... has been one filled with excitement, buzzer-beaters, and of course, ... busted, superstars have been made, and future professional products have ... down to the four teams that advanced through their regional ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... clinical trials and research, manage data results and ... their clients reach regulation standards. Contract research organizations ... medical device manufacturing sectors. Industry operators provide clients ... to late-stage clinical research for Food and Drug ...
Breaking Medicine News(10 mins):Health News:How to Turn Mid-life into the Good Life 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4
... Healthy, middle-aged smokers who take the most popular smoking cessation ... of being hospitalized with a heart attack or other serious ... Hopkins-led study suggests. "People want to quit smoking to ... they,re taking a drug that increases the risk for the ...
... Phoenix, AZ, USA July 4, 2011 VisionGate, ... the early detection of lung cancer, today announced that ... its LuCED test can improve the utility of low ... detection of lung cancer in high risk individuals. ...
... News) -- Staying hydrated is critical if you,re physically active ... so you need to assess your personal sweat rate, according ... "Sweat rate is very simple to calculate: weigh yourself ... half an hour and don,t drink or use the bathroom ...
... FRIDAY, July 1 (HealthDay News) -- Preschool children need to ... the true concept of counting, according to researchers. "We ... to involve counting. It,s only when children go beyond three ... are," lead author Elizabeth Gunderson, a graduate student in psychology ...
... , FRIDAY, July 1 (HealthDay News) -- A new ... a certain type of learning remarkable staying power. Over ... face or pattern from a larger group of images. They ... practice. When they were tested again one to two years ...
... citywide study published online in today,s issue of ... disparities in the use of clot-busting drugs to treat acute ... According to the study,s results, significantly fewer black patients receive ... emergency care and the presence of medical conditions that exclude ...
Cached Medicine News:Health News:Smokers using varenicline to quit the habit at greater risk of heart attack 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 3Health News:How to Stay Hydrated in Hot Weather 2Health News:Understanding Numbers Isn't as Simple as 1, 2, 3 2Health News:When It Comes to Memory, Practice Seems to Make Perfect 2Health News:Citywide study shows racial disparities in emergency stroke treatment 2
... High performance plus simple ... gentle and efficient washing ... is performed with minimum ... cells while membrane bound ...
Stat Fax 2600 is fully automatic microplate washer....
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap...
... a powerful, compact and programmable 2 ... vacuum and dispensing pumps. Dispense and ... vertical and horizontal needle positioning in ... wash and waste bottles and vacuum ...
Medicine Products: